Split vs. single-dose oral methotrexate in rheumatoid arthritis: a meta-analysis of randomized controlled trial
Inflammopharmacology · 2026-07 · 34 (7) · 4963-4965
DOI: 10.1007/s10787-026-02277-4 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Inflammopharmacology, online erschienen am 02.06.2026. Verfasst von Gabriela Stutz F Moreira und 1 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Federal Hospital of Servants of Rio de Janeiro, R. Sacadura Cabral, 178 - Saúde, Rio de Janeiro, Brazil. gabrielastutz@hotma…. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatology Department, Federal Hospital of Servants of Rio de Janeiro, R. Sacadura Cabral, 178 - Saúde, Rio de Janeiro, Brazil. gabrielastutz@hotmail.com.
- Federal University of Minas Gerais, Belo Horizonte, Brazil.
ORCID-Profile: Gabriela Stutz F Moreira
Zitieren
APA
Moreira, G. S. F., & Barbosa, L. M. (2026). Split vs. single-dose oral methotrexate in rheumatoid arthritis: a meta-analysis of randomized controlled trial. Inflammopharmacology, 34(7), 4963-4965. https://doi.org/10.1007/s10787-026-02277-4
Vancouver
Moreira GSF, Barbosa LM. Split vs. single-dose oral methotrexate in rheumatoid arthritis: a meta-analysis of randomized controlled trial. Inflammopharmacology. 2026;34(7):4963-4965. doi:10.1007/s10787-026-02277-4
BibTeX
@article{Moreira2026,
author = {Moreira, Gabriela Stutz F and Barbosa, Lucas M},
title = {Split vs. single-dose oral methotrexate in rheumatoid arthritis: a meta-analysis of randomized controlled trial},
journal = {Inflammopharmacology},
year = {2026},
volume = {34},
number = {7},
pages = {4963--4965},
doi = {10.1007/s10787-026-02277-4}
}
EUVIMED